NCT00838500

Brief Summary

The main objective of this study is to test the hypothesis that a 3 week intensive course of spa therapy can reduce the risk of leg ulcers in patients with advanced chronic venous insufficiency (C4a-b and C5 of the CEAP classification) at one year.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
425

participants targeted

Target at P50-P75 for phase_3

Timeline
Completed

Started May 2008

Typical duration for phase_3

Geographic Reach
1 country

13 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2008

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

February 5, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 6, 2009

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2011

Completed
Last Updated

October 1, 2012

Status Verified

September 1, 2012

Enrollment Period

2.6 years

First QC Date

February 5, 2009

Last Update Submit

September 28, 2012

Conditions

Keywords

Venous insufficiencyLeg ulcerbalneologyhydrotherapyModified Rutherford scoreEuroquol EQ 5d scaleCIVIQ2 scaleVisual analogic ScaleSPA treatment

Outcome Measures

Primary Outcomes (1)

  • Occurrence of a leg ulcer within the year following the inclusion. The ulcer will be classified C5 of CEAP (healed ulcer) or C6 (non healed ulcer)at the follow up visit.

    1 year

Secondary Outcomes (5)

  • Healing time of the leg ulcers within the first year

    12 months

  • Quality of life: Euroqol EQ 5D, CIVIQ2 Scale

    Inclusion - 6 months - 12 months- 18 months

  • Aggravation level defined as at least 20% increase of the modified Rutherford score and mean comparison of this score at 1 year

    Inclusion - 12 months - 18 months

  • Visual analog scale for leg symptoms

    Monthly (until 18 months)

  • Evaluation of the costs involved by the venous insufficiency at 1 year (treatments, physical treatments, hospitalization)

    Inclusion - 6, 12 and 18 months

Study Arms (2)

Immediate SPA treatment

ACTIVE COMPARATOR

Immediate spa treatment during 18 days soon after randomization (1 year)

Drug: Immediate spa treatment

Late SPA treatment

SHAM COMPARATOR

Late spa treatment during 18 days soon after 12 months visit (2nd year)

Drug: Late spa treatment

Interventions

1st year, soon after randomization: Spa treatment of 18 days. Spa treatment : the most adapted to the concerned pathology and common to all of spa resorts(walk in a specially pool, whirlpool bath with automatic air and water massages cycles, massaging shower...)

Immediate SPA treatment

2nd year, soon after 12 months visit: Spa treatment of 18 days. Spa treatment : the most adapted to the concerned pathology and common to all of spa resorts(walk in a specially pool, whirlpool bath with automatic air and water massages cycles, massaging shower...)

Late SPA treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Both sexes, more than 18 years old patients with a phlebological indication of spa treatment, with advanced chronic venous insufficiency, class C4a, or b or C5 of CEAP classification (leg ulcers must be healed since 3 months at least)
  • Available for a spa treatment during 18 days (immediate or late spa)and a follow-up period of 18 months
  • Voluntary to participate to the study,informed consent form signed after appropriate information
  • Affiliation to the social security system or equivalent

You may not qualify if:

  • Pregnancy, parturient or breast feeding
  • No psychiatric illness or social situation that would preclude study compliance
  • Leg ulcer in progress
  • Leg ulcer healed for less than 3 months
  • Refusal to consent
  • Refusal of spa treatment
  • Contra-indication of spa treatment(cancer in progress, psychiatric disorders, immunodeficiency)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (13)

Cabinet médical

Albertville, 73200, France

Location

Cabinet médical

Angoulême, 16000, France

Location

Cabinet médical

Bagnoles-de-l'Orne, 61140, France

Location

Cabinet médical

Barbotan-les-Thermes, 32150, France

Location

Cabinet médical

Bayonne, 64100, France

Location

Cabinet médical

Belfort, 90000, France

Location

Hopital thermal

Dax, 40100, France

Location

University Hospital Grenoble

Grenoble, 38043, France

Location

Cabinet médical

Montluçon, 03100, France

Location

Cabinet médical

Montpellier, 34000, France

Location

Cabinet médical

Pau, 64000, France

Location

Cabinet médical

Rochefort, 17300, France

Location

Cabinet médical

Tarbes, 65000, France

Location

Related Publications (10)

  • Carpentier PH, Maricq HR, Biro C, Poncot-Makinen CO, Franco A. Prevalence, risk factors, and clinical patterns of chronic venous disorders of lower limbs: a population-based study in France. J Vasc Surg. 2004 Oct;40(4):650-9. doi: 10.1016/j.jvs.2004.07.025.

    PMID: 15472591BACKGROUND
  • Carpentier PH, Satger B. Randomized trial of balneotherapy associated with patient education in patients with advanced chronic venous insufficiency. J Vasc Surg. 2009 Jan;49(1):163-70. doi: 10.1016/j.jvs.2008.07.075. Epub 2008 Oct 1.

    PMID: 18829219BACKGROUND
  • Ernst E, Saradeth T, Resch KL. A single blind randomized, controlled trial of hydrotherapy for varicose veins. Vasa. 1991;20(2):147-52.

    PMID: 1877335BACKGROUND
  • Eklof B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner RL, Meissner MH, Moneta GL, Myers K, Padberg FT, Perrin M, Ruckley CV, Smith PC, Wakefield TW; American Venous Forum International Ad Hoc Committee for Revision of the CEAP Classification. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004 Dec;40(6):1248-52. doi: 10.1016/j.jvs.2004.09.027.

    PMID: 15622385BACKGROUND
  • Rutherford RB, Padberg FT Jr, Comerota AJ, Kistner RL, Meissner MH, Moneta GL. Venous severity scoring: An adjunct to venous outcome assessment. J Vasc Surg. 2000 Jun;31(6):1307-12. doi: 10.1067/mva.2000.107094.

    PMID: 10842165BACKGROUND
  • Launois R, Reboul-Marty J, Henry B. Construction and validation of a quality of life questionnaire in chronic lower limb venous insufficiency (CIVIQ). Qual Life Res. 1996 Dec;5(6):539-54. doi: 10.1007/BF00439228.

    PMID: 8993100BACKGROUND
  • Constant F, Collin JF, Guillemin F, Boulange M. Effectiveness of spa therapy in chronic low back pain: a randomized clinical trial. J Rheumatol. 1995 Jul;22(7):1315-20.

    PMID: 7562765BACKGROUND
  • Labropoulos N, Leon LR Jr. Duplex evaluation of venous insufficiency. Semin Vasc Surg. 2005 Mar;18(1):5-9. doi: 10.1053/j.semvascsurg.2004.12.002.

    PMID: 15791546BACKGROUND
  • Prandoni P, Lensing AW, Prins MH, Frulla M, Marchiori A, Bernardi E, Tormene D, Mosena L, Pagnan A, Girolami A. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med. 2004 Aug 17;141(4):249-56. doi: 10.7326/0003-4819-141-4-200408170-00004.

    PMID: 15313740BACKGROUND
  • Carpentier PH, Blaise S, Satger B, Genty C, Rolland C, Roques C, Bosson JL. A multicenter randomized controlled trial evaluating balneotherapy in patients with advanced chronic venous insufficiency. J Vasc Surg. 2014 Feb;59(2):447-454.e1. doi: 10.1016/j.jvs.2013.08.002. Epub 2013 Oct 15.

Related Links

MeSH Terms

Conditions

Venous InsufficiencyLeg UlcerVaricose Ulcer

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesSkin UlcerSkin DiseasesSkin and Connective Tissue DiseasesVaricose Veins

Study Officials

  • Patrick PC CARPENTIER, Professor

    Grenoble Hospital - France

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 5, 2009

First Posted

February 6, 2009

Study Start

May 1, 2008

Primary Completion

December 1, 2010

Study Completion

November 1, 2011

Last Updated

October 1, 2012

Record last verified: 2012-09

Locations